Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)
Clinical trial NCT02906709 · COMPLETED
Trial details
- NCT number
- NCT02906709
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2018-08-21
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.